http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-30394-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfae81468523c4a7e635145a1bfe2359
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
filingDate 2007-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8ab6285a4f635794ebc7553b2c72069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9a7e121a7418e8ecd3f9d5e73866997
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5632d225fbdcdc110e04d18e192fb094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b527622b46ca309119c0acfcf79b52e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac2fbea8d663f10a004856fa5b9a0080
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b43341121b5f407214a4b257f540ed0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ea28cad66dd618c8a23d7edca763367
publicationDate 2007-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UY-30394-A1
titleOfInvention STABILIZED PHARMACEUTICAL COMPOSITIONS THAT INCLUDE FESOTERODINE
abstract The present application relates to a pharmaceutical composition comprising fesoteradine or its pharmaceutically acceptable salt or solvate and a stabilizer selected from the group comprising xylite, sorbitol, polydextrose, isomalt and dextrose.
priorityDate 2006-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88735

Total number of triples: 41.